UTI Asset Management Company Ltd.

“UTI AMC operates in one of Asia's best structural growth industries but has been the industry's biggest share loser for a decade, earns half the revenue yield of its best peer due to a low-fee ETF mix, generates sub-cost-of-equity ROE, and is governed by four competing PSU sponsors with no alignment to minority shareholders — a structure that produced an 18-month CEO vacancy and shows no signs of changing. At 31x trailing earnings with a 2.85x book multiple, the stock prices in a competitive recovery that has no empirical basis, offering an estimated 10-year base-case CAGR of 4–7% with meaningful downside if share losses accelerate. The only genuine option value is a PSU privatization event, but that is policy speculation, not an investment thesis. Capital is better deployed into higher-quality Indian AMC franchises or the broader index.”